Amgen recently bought cancer darling Oncovex for $1 Billion. About seven years ago Genzyme bought San Antonio biotech Ilex Oncology for $1 Billion dollars too. It looks like if you come up with the good data $1 billion is the magic buyout number.If you look into the roots of who really created Ilex Oncology. You will find the star was Alex Weis the co-founder he was their scientist; he brought in two awesome drugs from Sterling in San Antonio. Now he's at it again with Oncovista down in San Antonio. He has a tiny market cap of $12 million and $65 million in milestones over next 36 months potentially. And, two drug compounds with market potential of $1.35 billion. If OVIT repeats Ilex Oncology's success it has 100X upside potential.
the CEO is top notch and if their Adult Leukemia drug could have been approved for Hairy Cell Leukemia. However, the market was to small. I think this stock is going to be a major home run. This has tremendous upside potential given it's market cap is so small compared to all other cancer stocks listed.